Key result
MicroRNAs regulate cardiac mRNA translation across disease pathways, offering key diagnostic and therapeutic targets.
Answers are grounded in this paper and cite their sources.
MicroRNAs (miRNAs) are highly conserved, tiny (∼22 nucleotides) non-coding RNAs that have emerged as potent regulators of mRNA translation. miRNAs exhibit fine-tuning of the control of proteins involved in cell signalling (AE) pathways and in vital cellular and developmental processes. miRNAs are expressed in cardiovascular tissues, and multiple functional aspects of miRNAs underscore their key role in cardiovascular (patho)physiology. The development and increasing use of novel molecular biology tools have contributed to the recent success in miRNA research. In the present review, we discuss current updates on important and novel miRNA techniques, including: (i) miRNA screening tools; (ii) bioanalytical target prediction tools; (iii) target validation tools; and (iv) manipulative miRNA expression tools. We also present an update about recently identified miRNA targets that play a key role in cardiovascular development and disorders.
No takes yet. Share an insight, caveat, or question.
Dangwal et al. (2011) conducted a review in Cardiovascular development and disorders. MicroRNA research techniques and targets was evaluated. MicroRNAs (~22 nucleotides) regulate mRNA translation in cardiovascular pathophysiology, studied via screening, target prediction, validation, and expression manipulation tools.
Synapse has enriched 10 related papers. Consider them for comparative context: